B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 185,276 shares at $51.46 ($9.4M) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Scheduled sale ($9.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.46 | 25,113 | $1.3M | 13.8% |
| 2 | $51.46 | 25,113 | $1.3M | 13.8% |
| 3 | $50.23 | 50,000 | $2.5M | 26.8% |
| 4 | $50.19 | 42,525 | $2.1M | 22.8% |
| 5 | $50.19 | 42,525 | $2.1M | 22.8% |
| Total | $50.55 avg | 185,276 |
| $9.4M |
| 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |